Guanhao Biotech Co Ltd Cash Flow Reinvestment Rate
Guanhao Biotech Co Ltd cash flow reinvestment rate. Guanhao Biotech Co Ltd (300238) has a Cash Flow Reinvestment Rate of 0.46x as of December 2025, reinvesting CN¥8.58 Million (capex CN¥8.58 Million ) from operating cash flow of CN¥18.84 Million. See Guanhao Biotech Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guanhao Biotech Co Ltd (2007–2025)
Cash flow reinvestment rate of Guanhao Biotech Co Ltd from 2007 to 2025. Historical reinvestment intensity for Guanhao Biotech Co Ltd across 19 annual periods. Explore Guanhao Biotech Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Guanhao Biotech Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Guanhao Biotech Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Guanhao Biotech Co Ltd. For the full cash flow conversion analysis, see Guanhao Biotech Co Ltd (300238) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | CN¥41.01 Million | CN¥71.47 Million | CN¥38.17 Million | ▼ -65.1% |
| 2024 | 1.64x | CN¥81.48 Million | CN¥49.55 Million | CN¥76.20 Million | ▼ -15.2% |
| 2023 | 1.94x | CN¥105.03 Million | CN¥54.15 Million | CN¥53.92 Million | ▲ +219.7% |
| 2022 | 0.61x | CN¥43.06 Million | CN¥70.98 Million | CN¥41.17 Million | ▲ +906.7% |
| 2021 | 0.06x | CN¥7.38 Million | CN¥122.39 Million | CN¥4.71 Million | ▼ -51.5% |
| 2020 | 0.12x | CN¥12.89 Million | CN¥103.84 Million | CN¥2.90 Million | ▼ -10.3% |
| 2019 | 0.14x | CN¥12.81 Million | CN¥92.55 Million | CN¥6.32 Million | ▼ -93.3% |
| 2018 | 2.06x | CN¥66.54 Million | CN¥32.28 Million | CN¥33.65 Million | ▲ +12.4% |
| 2017 | 1.83x | CN¥35.23 Million | CN¥19.22 Million | CN¥31.88 Million | ▼ -88.7% |
| 2016 | 16.24x | CN¥498.16 Million | CN¥30.68 Million | CN¥64.18 Million | ▲ +5645.0% |
| 2015 | 0.28x | CN¥19.18 Million | CN¥67.87 Million | CN¥19.18 Million | ▼ -37.1% |
| 2014 | 0.45x | CN¥29.41 Million | CN¥65.45 Million | CN¥29.41 Million | ▼ -56.3% |
| 2013 | 1.03x | CN¥42.69 Million | CN¥41.49 Million | CN¥42.69 Million | ▼ -29.3% |
| 2012 | 1.45x | CN¥71.45 Million | CN¥49.12 Million | CN¥71.45 Million | ▼ -15.9% |
| 2011 | 1.73x | CN¥61.29 Million | CN¥35.45 Million | CN¥61.29 Million | ▲ +75.2% |
| 2010 | 0.99x | CN¥33.30 Million | CN¥33.76 Million | CN¥33.30 Million | ▼ -83.9% |
| 2009 | 6.14x | CN¥34.08 Million | CN¥5.55 Million | CN¥34.08 Million | ▲ +26.4% |
| 2008 | 4.86x | CN¥23.33 Million | CN¥4.80 Million | CN¥23.33 Million | ▲ +38.1% |
| 2007 | 3.52x | CN¥6.08 Million | CN¥1.73 Million | CN¥6.08 Million | — |